Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
LPI (LP Information)' newest research report, the "Drug-Device Combination Products Industry Forecast" looks at past sales and reviews total world Drug-Device Combination Products sales in 2022, providing a comprehensive analysis by region and market sector of projected Drug-Device Combination Products sales for 2023 through 2029. With Drug-Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug-Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug-Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug-Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Drug-Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug-Device Combination Products and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug-Device Combination Products.
The global Drug-Device Combination Products market size is projected to grow from US$ 34430 million in 2022 to US$ 53420 million in 2029; it is expected to grow at a CAGR of 6.5% from 2023 to 2029.
Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.
In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug-Device Combination Products market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Drug-Coated Device
- Prefilled Drug Delivery Systems
- Nebulizer and Inhaler
- Transdermal Delivery System
- Others
Segmentation by application
- Hospital andClinic
- Retail Pharmacies
- Other
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- GSK
- Novo Nordisk
- Eli Lilly
- AstraZeneca
- Sanofi
- Boston Scientific
- Abbott
- Boehringer Ingelheim
- Medtronic
- Mylan
- 3M
- Hisamitsu
- Smith & Nephew
- Molnlycke
- Teleflex
- BD
- Lepu Medical
- MicroPort
- Terumo
- B. Braun
- Antares Pharma
Global Drug-Device Combination Products Market Growth (Status and Outlook) 2023-2029
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug-Device Combination Products Market Size 2018-2029
2.1.2 Drug-Device Combination Products Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Drug-Device Combination Products Segment by Type
2.2.1 Drug-Coated Device
2.2.2 Prefilled Drug Delivery Systems
2.2.3 Nebulizer and Inhaler
2.2.4 Transdermal Delivery System
2.2.5 Others
2.3 Drug-Device Combination Products Market Size by Type
2.3.1 Drug-Device Combination Products Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
2.4 Drug-Device Combination Products Segment by Application
2.4.1 Hospital andClinic
2.4.2 Retail Pharmacies
2.4.3 Other
2.5 Drug-Device Combination Products Market Size by Application
2.5.1 Drug-Device Combination Products Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
3 Drug-Device Combination Products Market Size by Player
3.1 Drug-Device Combination Products Market Size Market Share by Players
3.1.1 Global Drug-Device Combination Products Revenue by Players (2018-2023)
3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2018-2023)
3.2 Global Drug-Device Combination Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug-Device Combination Products by Regions
4.1 Drug-Device Combination Products Market Size by Regions (2018-2023)
4.2 Americas Drug-Device Combination Products Market Size Growth (2018-2023)
4.3 APAC Drug-Device Combination Products Market Size Growth (2018-2023)
4.4 Europe Drug-Device Combination Products Market Size Growth (2018-2023)
4.5 Middle East & Africa Drug-Device Combination Products Market Size Growth (2018-2023)
5 Americas
5.1 Americas Drug-Device Combination Products Market Size by Country (2018-2023)
5.2 Americas Drug-Device Combination Products Market Size by Type (2018-2023)
5.3 Americas Drug-Device Combination Products Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug-Device Combination Products Market Size by Region (2018-2023)
6.2 APAC Drug-Device Combination Products Market Size by Type (2018-2023)
6.3 APAC Drug-Device Combination Products Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug-Device Combination Products by Country (2018-2023)
7.2 Europe Drug-Device Combination Products Market Size by Type (2018-2023)
7.3 Europe Drug-Device Combination Products Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug-Device Combination Products by Region (2018-2023)
8.2 Middle East & Africa Drug-Device Combination Products Market Size by Type (2018-2023)
8.3 Middle East & Africa Drug-Device Combination Products Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug-Device Combination Products Market Forecast
10.1 Global Drug-Device Combination Products Forecast by Regions (2024-2029)
10.1.1 Global Drug-Device Combination Products Forecast by Regions (2024-2029)
10.1.2 Americas Drug-Device Combination Products Forecast
10.1.3 APAC Drug-Device Combination Products Forecast
10.1.4 Europe Drug-Device Combination Products Forecast
10.1.5 Middle East & Africa Drug-Device Combination Products Forecast
10.2 Americas Drug-Device Combination Products Forecast by Country (2024-2029)
10.2.1 United States Drug-Device Combination Products Market Forecast
10.2.2 Canada Drug-Device Combination Products Market Forecast
10.2.3 Mexico Drug-Device Combination Products Market Forecast
10.2.4 Brazil Drug-Device Combination Products Market Forecast
10.3 APAC Drug-Device Combination Products Forecast by Region (2024-2029)
10.3.1 China Drug-Device Combination Products Market Forecast
10.3.2 Japan Drug-Device Combination Products Market Forecast
10.3.3 Korea Drug-Device Combination Products Market Forecast
10.3.4 Southeast Asia Drug-Device Combination Products Market Forecast
10.3.5 India Drug-Device Combination Products Market Forecast
10.3.6 Australia Drug-Device Combination Products Market Forecast
10.4 Europe Drug-Device Combination Products Forecast by Country (2024-2029)
10.4.1 Germany Drug-Device Combination Products Market Forecast
10.4.2 France Drug-Device Combination Products Market Forecast
10.4.3 UK Drug-Device Combination Products Market Forecast
10.4.4 Italy Drug-Device Combination Products Market Forecast
10.4.5 Russia Drug-Device Combination Products Market Forecast
10.5 Middle East & Africa Drug-Device Combination Products Forecast by Region (2024-2029)
10.5.1 Egypt Drug-Device Combination Products Market Forecast
10.5.2 South Africa Drug-Device Combination Products Market Forecast
10.5.3 Israel Drug-Device Combination Products Market Forecast
10.5.4 Turkey Drug-Device Combination Products Market Forecast
10.5.5 GCC Countries Drug-Device Combination Products Market Forecast
10.6 Global Drug-Device Combination Products Forecast by Type (2024-2029)
10.7 Global Drug-Device Combination Products Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 GSK
11.1.1 GSK Company Information
11.1.2 GSK Drug-Device Combination Products Product Offered
11.1.3 GSK Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GSK Main Business Overview
11.1.5 GSK Latest Developments
11.2 Novo Nordisk
11.2.1 Novo Nordisk Company Information
11.2.2 Novo Nordisk Drug-Device Combination Products Product Offered
11.2.3 Novo Nordisk Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novo Nordisk Main Business Overview
11.2.5 Novo Nordisk Latest Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Drug-Device Combination Products Product Offered
11.3.3 Eli Lilly Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Eli Lilly Main Business Overview
11.3.5 Eli Lilly Latest Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Company Information
11.4.2 AstraZeneca Drug-Device Combination Products Product Offered
11.4.3 AstraZeneca Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 AstraZeneca Main Business Overview
11.4.5 AstraZeneca Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Drug-Device Combination Products Product Offered
11.5.3 Sanofi Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 Boston Scientific
11.6.1 Boston Scientific Company Information
11.6.2 Boston Scientific Drug-Device Combination Products Product Offered
11.6.3 Boston Scientific Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Boston Scientific Main Business Overview
11.6.5 Boston Scientific Latest Developments
11.7 Abbott
11.7.1 Abbott Company Information
11.7.2 Abbott Drug-Device Combination Products Product Offered
11.7.3 Abbott Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Abbott Main Business Overview
11.7.5 Abbott Latest Developments
11.8 Boehringer Ingelheim
11.8.1 Boehringer Ingelheim Company Information
11.8.2 Boehringer Ingelheim Drug-Device Combination Products Product Offered
11.8.3 Boehringer Ingelheim Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Boehringer Ingelheim Main Business Overview
11.8.5 Boehringer Ingelheim Latest Developments
11.9 Medtronic
11.9.1 Medtronic Company Information
11.9.2 Medtronic Drug-Device Combination Products Product Offered
11.9.3 Medtronic Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Medtronic Main Business Overview
11.9.5 Medtronic Latest Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Drug-Device Combination Products Product Offered
11.10.3 Mylan Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Mylan Main Business Overview
11.10.5 Mylan Latest Developments
11.11 3M
11.11.1 3M Company Information
11.11.2 3M Drug-Device Combination Products Product Offered
11.11.3 3M Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 3M Main Business Overview
11.11.5 3M Latest Developments
11.12 Hisamitsu
11.12.1 Hisamitsu Company Information
11.12.2 Hisamitsu Drug-Device Combination Products Product Offered
11.12.3 Hisamitsu Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Hisamitsu Main Business Overview
11.12.5 Hisamitsu Latest Developments
11.13 Smith & Nephew
11.13.1 Smith & Nephew Company Information
11.13.2 Smith & Nephew Drug-Device Combination Products Product Offered
11.13.3 Smith & Nephew Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Smith & Nephew Main Business Overview
11.13.5 Smith & Nephew Latest Developments
11.14 Molnlycke
11.14.1 Molnlycke Company Information
11.14.2 Molnlycke Drug-Device Combination Products Product Offered
11.14.3 Molnlycke Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Molnlycke Main Business Overview
11.14.5 Molnlycke Latest Developments
11.15 Teleflex
11.15.1 Teleflex Company Information
11.15.2 Teleflex Drug-Device Combination Products Product Offered
11.15.3 Teleflex Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Teleflex Main Business Overview
11.15.5 Teleflex Latest Developments
11.16 BD
11.16.1 BD Company Information
11.16.2 BD Drug-Device Combination Products Product Offered
11.16.3 BD Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 BD Main Business Overview
11.16.5 BD Latest Developments
11.17 Lepu Medical
11.17.1 Lepu Medical Company Information
11.17.2 Lepu Medical Drug-Device Combination Products Product Offered
11.17.3 Lepu Medical Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 Lepu Medical Main Business Overview
11.17.5 Lepu Medical Latest Developments
11.18 MicroPort
11.18.1 MicroPort Company Information
11.18.2 MicroPort Drug-Device Combination Products Product Offered
11.18.3 MicroPort Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 MicroPort Main Business Overview
11.18.5 MicroPort Latest Developments
11.19 Terumo
11.19.1 Terumo Company Information
11.19.2 Terumo Drug-Device Combination Products Product Offered
11.19.3 Terumo Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.19.4 Terumo Main Business Overview
11.19.5 Terumo Latest Developments
11.20 B. Braun
11.20.1 B. Braun Company Information
11.20.2 B. Braun Drug-Device Combination Products Product Offered
11.20.3 B. Braun Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.20.4 B. Braun Main Business Overview
11.20.5 B. Braun Latest Developments
11.21 Antares Pharma
11.21.1 Antares Pharma Company Information
11.21.2 Antares Pharma Drug-Device Combination Products Product Offered
11.21.3 Antares Pharma Drug-Device Combination Products Revenue, Gross Margin and Market Share (2018-2023)
11.21.4 Antares Pharma Main Business Overview
11.21.5 Antares Pharma Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Drug-Device Combination Products Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Drug-Coated Device
Table 3. Major Players of Prefilled Drug Delivery Systems
Table 4. Major Players of Nebulizer and Inhaler
Table 5. Major Players of Transdermal Delivery System
Table 6. Major Players of Others
Table 7. Drug-Device Combination Products Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Drug-Device Combination Products Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Table 10. Drug-Device Combination Products Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Drug-Device Combination Products Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Table 13. Global Drug-Device Combination Products Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Drug-Device Combination Products Revenue Market Share by Player (2018-2023)
Table 15. Drug-Device Combination Products Key Players Head office and Products Offered
Table 16. Drug-Device Combination Products Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Drug-Device Combination Products Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Drug-Device Combination Products Market Size Market Share by Regions (2018-2023)
Table 21. Global Drug-Device Combination Products Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Drug-Device Combination Products Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Drug-Device Combination Products Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Drug-Device Combination Products Market Size Market Share by Country (2018-2023)
Table 25. Americas Drug-Device Combination Products Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Table 27. Americas Drug-Device Combination Products Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Table 29. APAC Drug-Device Combination Products Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Drug-Device Combination Products Market Size Market Share by Region (2018-2023)
Table 31. APAC Drug-Device Combination Products Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Table 33. APAC Drug-Device Combination Products Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Table 35. Europe Drug-Device Combination Products Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Drug-Device Combination Products Market Size Market Share by Country (2018-2023)
Table 37. Europe Drug-Device Combination Products Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Table 39. Europe Drug-Device Combination Products Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Drug-Device Combination Products Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Drug-Device Combination Products Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Drug-Device Combination Products Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Drug-Device Combination Products
Table 48. Key Market Challenges & Risks of Drug-Device Combination Products
Table 49. Key Industry Trends of Drug-Device Combination Products
Table 50. Global Drug-Device Combination Products Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Drug-Device Combination Products Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Drug-Device Combination Products Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Drug-Device Combination Products Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. GSK Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 55. GSK Drug-Device Combination Products Product Offered
Table 56. GSK Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. GSK Main Business
Table 58. GSK Latest Developments
Table 59. Novo Nordisk Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 60. Novo Nordisk Drug-Device Combination Products Product Offered
Table 61. Novo Nordisk Main Business
Table 62. Novo Nordisk Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Novo Nordisk Latest Developments
Table 64. Eli Lilly Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 65. Eli Lilly Drug-Device Combination Products Product Offered
Table 66. Eli Lilly Main Business
Table 67. Eli Lilly Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Eli Lilly Latest Developments
Table 69. AstraZeneca Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 70. AstraZeneca Drug-Device Combination Products Product Offered
Table 71. AstraZeneca Main Business
Table 72. AstraZeneca Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. AstraZeneca Latest Developments
Table 74. Sanofi Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 75. Sanofi Drug-Device Combination Products Product Offered
Table 76. Sanofi Main Business
Table 77. Sanofi Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. Sanofi Latest Developments
Table 79. Boston Scientific Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 80. Boston Scientific Drug-Device Combination Products Product Offered
Table 81. Boston Scientific Main Business
Table 82. Boston Scientific Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. Boston Scientific Latest Developments
Table 84. Abbott Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 85. Abbott Drug-Device Combination Products Product Offered
Table 86. Abbott Main Business
Table 87. Abbott Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Abbott Latest Developments
Table 89. Boehringer Ingelheim Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 90. Boehringer Ingelheim Drug-Device Combination Products Product Offered
Table 91. Boehringer Ingelheim Main Business
Table 92. Boehringer Ingelheim Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Boehringer Ingelheim Latest Developments
Table 94. Medtronic Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 95. Medtronic Drug-Device Combination Products Product Offered
Table 96. Medtronic Main Business
Table 97. Medtronic Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Medtronic Latest Developments
Table 99. Mylan Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 100. Mylan Drug-Device Combination Products Product Offered
Table 101. Mylan Main Business
Table 102. Mylan Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Mylan Latest Developments
Table 104. 3M Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 105. 3M Drug-Device Combination Products Product Offered
Table 106. 3M Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 107. 3M Main Business
Table 108. 3M Latest Developments
Table 109. Hisamitsu Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 110. Hisamitsu Drug-Device Combination Products Product Offered
Table 111. Hisamitsu Main Business
Table 112. Hisamitsu Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 113. Hisamitsu Latest Developments
Table 114. Smith & Nephew Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 115. Smith & Nephew Drug-Device Combination Products Product Offered
Table 116. Smith & Nephew Main Business
Table 117. Smith & Nephew Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 118. Smith & Nephew Latest Developments
Table 119. Molnlycke Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 120. Molnlycke Drug-Device Combination Products Product Offered
Table 121. Molnlycke Main Business
Table 122. Molnlycke Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 123. Molnlycke Latest Developments
Table 124. Teleflex Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 125. Teleflex Drug-Device Combination Products Product Offered
Table 126. Teleflex Main Business
Table 127. Teleflex Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 128. Teleflex Latest Developments
Table 129. BD Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 130. BD Drug-Device Combination Products Product Offered
Table 131. BD Main Business
Table 132. BD Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 133. BD Latest Developments
Table 134. Lepu Medical Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 135. Lepu Medical Drug-Device Combination Products Product Offered
Table 136. Lepu Medical Main Business
Table 137. Lepu Medical Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 138. Lepu Medical Latest Developments
Table 139. MicroPort Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 140. MicroPort Drug-Device Combination Products Product Offered
Table 141. MicroPort Main Business
Table 142. MicroPort Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 143. MicroPort Latest Developments
Table 144. Terumo Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 145. Terumo Drug-Device Combination Products Product Offered
Table 146. Terumo Main Business
Table 147. Terumo Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 148. Terumo Latest Developments
Table 149. B. Braun Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 150. B. Braun Drug-Device Combination Products Product Offered
Table 151. B. Braun Main Business
Table 152. B. Braun Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 153. B. Braun Latest Developments
Table 154. Antares Pharma Details, Company Type, Drug-Device Combination Products Area Served and Its Competitors
Table 155. Antares Pharma Drug-Device Combination Products Product Offered
Table 156. Antares Pharma Drug-Device Combination Products Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 157. Antares Pharma Main Business
Table 158. Antares Pharma Latest Developments
List of Figures
Figure 1. Drug-Device Combination Products Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drug-Device Combination Products Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Drug-Device Combination Products Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Drug-Device Combination Products Sales Market Share by Country/Region (2022)
Figure 8. Drug-Device Combination Products Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Drug-Device Combination Products Market Size Market Share by Type in 2022
Figure 10. Drug-Device Combination Products in Hospital andClinic
Figure 11. Global Drug-Device Combination Products Market: Hospital andClinic (2018-2023) & ($ Millions)
Figure 12. Drug-Device Combination Products in Retail Pharmacies
Figure 13. Global Drug-Device Combination Products Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Drug-Device Combination Products in Other
Figure 15. Global Drug-Device Combination Products Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Drug-Device Combination Products Market Size Market Share by Application in 2022
Figure 17. Global Drug-Device Combination Products Revenue Market Share by Player in 2022
Figure 18. Global Drug-Device Combination Products Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Drug-Device Combination Products Market Size 2018-2023 ($ Millions)
Figure 20. APAC Drug-Device Combination Products Market Size 2018-2023 ($ Millions)
Figure 21. Europe Drug-Device Combination Products Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Drug-Device Combination Products Market Size 2018-2023 ($ Millions)
Figure 23. Americas Drug-Device Combination Products Value Market Share by Country in 2022
Figure 24. United States Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Drug-Device Combination Products Market Size Market Share by Region in 2022
Figure 29. APAC Drug-Device Combination Products Market Size Market Share by Type in 2022
Figure 30. APAC Drug-Device Combination Products Market Size Market Share by Application in 2022
Figure 31. China Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Drug-Device Combination Products Market Size Market Share by Country in 2022
Figure 38. Europe Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Figure 39. Europe Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Figure 40. Germany Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Drug-Device Combination Products Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Drug-Device Combination Products Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Drug-Device Combination Products Market Size 2024-2029 ($ Millions)
Figure 54. APAC Drug-Device Combination Products Market Size 2024-2029 ($ Millions)
Figure 55. Europe Drug-Device Combination Products Market Size 2024-2029
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
